StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
NATHBIOGEN.NS$174.97+1.29%
Fair $174.97+0.0%

NATHBIOGEN.NS

Nath Bio-Genes (India) Limited

Basic Materials / Agricultural InputsNSE

$174.97

+2.26 (+1.29%)

Fairly Valued+0.0%Fair Value $174.97Fund rank 30/100 · Data gapFallback financials|
SA 51/C
F-Score: 4/9
Margin Compression

FCF base 3Y

n/d

n/d CAGR · yield n/d

FCF base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 32% · confianza 23%

FCF escenarios

weak_data · normalized FCF $96.6M · quality 50.7/100

Data gap 30/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 31/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

51/100

C

Piotroski

4/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

16/100

SEC 0%

Latest source: unknownPeriods: 4Warnings: 1unknown: 4
No SEC-backed annual rows; valuation uses fallback financial data. Sector-specific commodity mid-cycle model required: targets are disabled until normalized cycle price/cost-curve/reserve data exists. Operating margin has declined for 3 consecutive years
Thesis & Journal · NATHBIOGEN.NSLocal privado en este navegador · Nath Bio-Genes (India) Limited
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$3.3B

P/E

8.3x

↓

EV/EBITDA

6.2x

↓

ROE

6.1%

↑

Gross Margin

54.7%

↑

Debt/Equity

0.20

↓
52-Week Range$175
$126$239

TradingView lightweight chart

NATHBIOGEN.NS price, volumen y niveles de valoración

Último $177.44Periodo +745.0%
Fair value: $174.97

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2023–2026 · 3 años de histórico normalizado

Revenue CAGR

+13.9%

FCF CAGR

—

FCF margin

-3.5%

FCF / Net income

-0.37x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $4.45B · net income $416.3M · FCF $-155.8M

2023-FY → 2026-FY

Gross margin

54.7%-7.2% pts

Operating margin

10.9%-4.4% pts

Net margin

9.4%-2.3% pts

FCF margin

-3.5%-15.4% pts
MetricTTM
2026
2025
2024
2023
Income Statement
Revenue$4.45B$4.45B$3.65B$3.33B$3.01B
Net Income$416.3M$416.3M$386.0M$396.2M$350.1M
EBITDA$662.6M$662.6M$543.4M$567.2M$517.6M
EPS20.9820.9820.1420.8518.43
Gross Margin54.7%54.7%62.9%65.9%62.0%
Operating Margin10.9%10.9%12.6%14.1%15.3%
Net Margin9.4%9.4%10.6%11.9%11.6%
Balance Sheet
Debt/Equity0.200.200.190.180.18
Current Ratio1.971.97———
Cash Flow
Free Cash Flow$-155.8M$-155.8M$96.6M$478.2M$358.2M
Returns
ROE6.1%6.1%6.0%6.5%6.1%
Valuation
P/E8.348.347.839.188.12
EV/EBITDA6.186.186.197.006.79
P/B0.510.510.470.600.50
Growth & Yield
Revenue Growth22.0%22.0%9.7%10.4%—
EPS Growth4.2%4.2%-3.4%13.1%—
Dividend Yield1.1%1.1%———

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%

3Y implied EPS CAGR

-9.5%

fácil

EPS terminal req.

$15.53

Spread vs growth

13.7%

5Y implied EPS CAGR

-2.2%

fácil

EPS terminal req.

$18.79

Spread vs growth

6.4%

10Y implied EPS CAGR

3.7%

fácil

EPS terminal req.

$30.26

Spread vs growth

0.4%

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total -7.7%

Total return

-7.7%

Start / end P/E

9.7x → 8.5x

EPS bridge

20.14 → 20.98

Residual

-0.5%

EPS growth+4.2%
Multiple rerating-12.5%
Dividend+1.1%
Residual / FX / buybacks / cross-term-0.5%

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.